CERTA THERAPEUTICS
Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.
CERTA THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.certatherapeutics.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Nginx
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.certatherapeutics.com
- Host name: 45-79-237-164.ip.linodeusercontent.com
- IP address: 45.79.237.164
- Location: Fremont United States
- Latitude: 37.5625
- Longitude: -122.0004
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94536
More informations about "Certa Therapeutics"
About – Certa Therapeutics
Having identified and validated the role of GPR68, a G protein-coupled receptor (GPCR) receptor, as a switch regulating fibrosis, the company has built a platform to discover candidate drugs as potential treatments for multiple fibrotic …See details»
Management Team – Certa Therapeutics
The lead asset in the portfolio is Asengeprast (FT011), which was initially developed by Dr Kelly in a company called Fibrotech which he spun out of the University of Melbourne and was later sold to Shire with Certa then regaining …See details»
Certa Therapeutics - Crunchbase Company Profile
Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.See details»
Certa Therapeutics Company Profile | Management and ... - Datanyze
Www.certatherapeutics.com . Certa Therapeutics Profile and History. Certa Therapeutics is a late stage biotechnology company based in Melbourne that is working on a treatment for kidney …See details»
Certa Therapeutics - LinkedIn
Certa Therapeutics | 1,137 followers on LinkedIn. Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases | Certa Therapeutics is a biotechnology …See details»
Certa Therapeutics - PitchBook
Certa Therapeutics General Information Description. Operator of a biotechnology and drug development company intended to help treat fibrotic diseases. The company develops drugs …See details»
Certa Therapeutics - VentureRadar
"Certa Therapeutics, based in Melbourne, Australia, is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.See details»
Certa Therapeutics - Overview, News & Similar companies
Feb 5, 2023 www.certatherapeutics.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Certa Therapeutics' FT011 Granted US …See details»
Certa Therapeutics - Craft
Certa Therapeutics is a biotechnology company developing therapies for the treatment of fibrotic diseases. Its initial focus is on the providing of treatments for chronic kidney disease (CKD).See details»
Certa Therapeutics Pty Ltd. - Drug pipelines, Patents ... - Patsnap
Certatherapeutics.com. Startups | Holding Company | 2018 | Australia | < 10 | certatherapeutics.com. Last update 24 Dec 2024. Overview. Pipeline. Deal. Translational …See details»
Certa Therapeutics - Company Profile - Tracxn
Oct 22, 2024 Email ID: *****@certatherapeutics.com; Key Metrics. Total Funding. $3M in 1 round. Latest Funding Round. Seed, Jun 05, 2018, $3M. Investors. Brandon Capital & 3 more. …See details»
Board of Directors – Certa Therapeutics
Concurrent to his role with Certa Therapeutics, Darren is Executive Chair and Founder of OccuRx, Venture partner (Entrepreneur in Residence) with Brandon Capital, a Board Director …See details»
Certa Therapeutics - Products, Competitors, Financials, Employees ...
Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011) Sep 24, 2024, September 16, 2024 – Melbourne, Australia 16 …See details»
Certa Therapeutics - Uniseed
Website: www.certatherapeutics.com. Certa Therapeutics is a late stage biotechnology company based in Melbourne that is working on a treatment for diseases characterised by fibrosis and …See details»
CERTA THERAPEUTICS PTY LTD - Dun & Bradstreet
See other industries within the Manufacturing sector: Aerospace Product and Parts Manufacturing , Agriculture, Construction, and Mining Machinery Manufacturing , Alumina and Aluminum …See details»
Certa Therapeutics – Funding, Valuation, Investors, News
Feb 19, 2024 Certa Therapeutics is focused on the emerging field of medical science which uses genetic information to identify which patients will best respond to a specific treatment, …See details»
Certa Therapeutics Management Team | Org Chart - RocketReach
Certatherapeutics.com; View Similar People. Related Companies Applied Horticultural Research. 24 $6m Imugene Limited. 56 $5.9m Solbari. 22 $5.1m Dovetail. 180 Ergoport Pty Ltd. 10 $1m …See details»
Certa Therapeutics team to meet with biotech industry leaders …
Melbourne, Australia, 20 October 2022: Certa Therapeutics, a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and fibrotic …See details»
Certa Therapeutics - Brandon Capital
San Francisco. Brandon Capital LLC. 1 Letterman Ave, Suite C3-330. San Francisco, CA 94129. Phone +61 3 9657 0700. Email: [email protected]See details»